The new new contracts, who’s behind them, and what they mean — delivered to your inbox every week. No credit card, unsubscribe anytime.
Weekly Digest
New new contracts, summarized for you
Straight to Inbox
No login, no app to check — it comes to you
Contract Trends
See who's moving and how much in your market
No credit card required Weekly contract digest
ADIA Invests $200 Million for a 3% Stake in Meril Life Sciences to Support MedTech Innovations.
Jul 20, 2025•11 months ago
Contract Type
investment
VapiManufacturingHealth Care
Description
ADIA is set to invest USD 200 million in Meril Life Sciences for a 3% stake, valuing the company at USD 6.6 billion. This strategic investment aims to bolster Meril's growth in the medical devices sector and is pending regulatory approval from the Competition Commission of India.
Company Information
Company
Meril Life Sciences Private Limited
Location
Vapi, Gujarat, India
About
Founded by the Bilakhia Group, Meril is a global innovator in medical technology, with a strong focus on clinically advanced solutions across multiple specialties. They operate state-of-the-art manufacturing facilities and have a global presence, serving healthcare systems in over 150 countries. Meril is committed to sustainable innovation and is working towards becoming the world's leading MedTech company powered by green energy.
Predictive Intelligence
Strategic
ML-powered predictions for Meril Life Sciences Private Limited's next move
VapiManufacturingHealth Care